Ying Li

Ying Li

Auto-generated profile, based on publicly available information

Ying Li

Outpatient Department of Yangfangdian, Southern Medical District of Chinese PLA General Hospital, Beijing, 100843, People’s Republic of China

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 July 2022 in Journal of Agricultural and Food Chemistry
Verified
Journal Article
Closed access
CYChuanyu Yang
Chuanyu Yang
PYPeitong Yu
Peitong Yu
YLYing Li
Ying Li
JWJunyang Wang
Junyang Wang
XMXinyue Ma
Xinyue Ma
CSChunyan Sun
Chunyan Sun

21 November 2023 in Microchemical Journal
Verified
Journal Article
Closed access
RSRumeng Song
Rumeng Song
YLYing Li
Ying Li
CZChi Zhang
Chi Zhang
GLGaiping Li
Gaiping Li
LZLina Zou
Lina Zou

1 November 2024 in Clinical, Cosmetic and Investigational Dermatology
Verified
Journal Article
Open access
PDF file
XWXudong Wang
Xudong Wang
ZLZhiyong Li
Zhiyong Li
JXJianhong Xu
Jianhong Xu
JWJun Wang
Jun Wang
YLYing Li
Ying Li
RYRongya Yang
Rongya Yang
Purpose: Heat shock protein A4 (HSPA4) is associated with a variety of human diseases. However, its function in cutaneous malignant melanoma (CMM) remains uncertain. Patients and Methods: The gene and protein expression level of HSPA4 in CMM was investigated with public databases. Cell Counting Kit-8 (CCK8) assay was performed to assess the effect of HSPA4 on the proliferation of melanoma cells. Then, the diagnostic and prognostic value of HSPA4 in CMM were analyzed. Gene variations and methylation levels, and the correlation between HSPA4 expression and immune cell infiltration were evaluated, followed by the construction of HSPA4 related protein-protein interaction networks and functional enrichment analysis. Results: The mRNA and protein expression level of HSPA4 was significantly higher in CMM. Knocking down HSPA4 in A-375 cell line could inhibit tumor cell growth. The receiver operating characteristic (ROC) curve analysis confirmed the diagnostic value of HSPA4. Survival analysis showed that high expression of HSPA4 was associated with poor prognosis. HSPA4 gene alterations were observed in 3% of CMM patients. Five CpG sites are associated with the prognosis of CMM. HSPA4 is negatively correlated with most immune cells in CMM. The protein interaction network shows that HSPA4 is closely related to proteins such as DnaJ heat shock protein family (Hsp40) member B1 (DNAJB1) and DnaJ heat shock protein family (Hsp40) member B6 (DNAJB6), and the expression of DNAJB1 is positively correlated with HSPA4. Functional enrichment analysis indicated that HSPA4 may be associated with immune suppression and immune escape within the tumor microenvironment of CMM. Conclusion: HSPA4 may participate in the regulation of tumor development and microenvironment, which may be a potential diagnostic and prognostic marker of CMM.